OncoMyx Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Out of Business

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Out of Business

OncoMyx Therapeutics General Information

Description

Developer of oncolytic immunotherapies designed to assist in creating an immune response and treat cancer. The company's virus and immunotherapies target hematologic and solid tumors with a unique oncolytic virus and a novel patented systemic delivery approach that can be carried systemically by human leukocytes where it can then infect tumor cells, enabling doctors to orchestrate an immune response and treat cancer.

Contact Information

Website
www.oncomyx.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 445 North Fifth Street
  • Phoenix, AZ 85004
  • United States
+1 (858)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 445 North Fifth Street
  • Phoenix, AZ 85004
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoMyx Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Jul-2022 Completed Out of Business
4. Early Stage VC (Series B) 08-Dec-2021 Completed Generating Revenue
3. Debt - PPP 15-Apr-2020 Completed Generating Revenue
2. Early Stage VC (Series A) 14-Jun-2019 $25M $25M Completed Generating Revenue
1. University Spin-Out 01-Jan-2018 Completed Startup
To view OncoMyx Therapeutics’s complete valuation and funding history, request access »

OncoMyx Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view OncoMyx Therapeutics’s complete cap table history, request access »

OncoMyx Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of oncolytic immunotherapies designed to assist in creating an immune response and treat cancer. The company's
Biotechnology
Phoenix, AZ
13 As of 2023

Houston, TX
 

Helsinki, Finland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OncoMyx Therapeutics Competitors (41)

One of OncoMyx Therapeutics’s 41 competitors is DNAtrix, a Venture Capital-Backed company based in Houston, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DNAtrix Venture Capital-Backed Houston, TX
TILT Biotherapeutics Venture Capital-Backed Helsinki, Finland
ViraTherapeutics Formerly VC-backed Rum, Austria
Senti Biosciences Holdings Formerly VC-backed South San Francisco, CA
Kite Pharma Formerly VC-backed Santa Monica, CA
You’re viewing 5 of 41 competitors. Get the full list »

OncoMyx Therapeutics Patents

OncoMyx Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022229726-A1 Multi-armed myxoma virus Inactive 01-Mar-2021
CA-3210350-A1 Multi-armed myxoma virus Pending 01-Mar-2021
EP-4301387-A2 Multi-armed myxoma virus Inactive 01-Mar-2021
EP-4301387-A4 Multi-armed myxoma virus Inactive 01-Mar-2021
WO-2022187148-A2 Multi-armed myxoma virus Inactive 01-Mar-2021 A61K35/768
To view OncoMyx Therapeutics’s complete patent history, request access »

OncoMyx Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoMyx Therapeutics FAQs

  • When was OncoMyx Therapeutics founded?

    OncoMyx Therapeutics was founded in 2018.

  • Where is OncoMyx Therapeutics headquartered?

    OncoMyx Therapeutics is headquartered in Phoenix, AZ.

  • What is the size of OncoMyx Therapeutics?

    OncoMyx Therapeutics has 13 total employees.

  • What industry is OncoMyx Therapeutics in?

    OncoMyx Therapeutics’s primary industry is Biotechnology.

  • Is OncoMyx Therapeutics a private or public company?

    OncoMyx Therapeutics is a Private company.

  • What is OncoMyx Therapeutics’s current revenue?

    The current revenue for OncoMyx Therapeutics is .

  • How much funding has OncoMyx Therapeutics raised over time?

    OncoMyx Therapeutics has raised $75M.

  • Who are OncoMyx Therapeutics’s competitors?

    DNAtrix, TILT Biotherapeutics, ViraTherapeutics, Senti Biosciences Holdings, and Kite Pharma are some of the 41 competitors of OncoMyx Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process